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Abstract 
Alongside its immediate implications for pregnancy complications, increasing evidence 
implicates maternal obesity as a major determinant of health in the offspring during 
childhood and later adult life. Observational studies provide evidence for effects of maternal 
obesity on the offspring’s risks of obesity, coronary heart disease, stroke, type 2 diabetes 
and asthma. Maternal obesity may also lead to poorer cognitive performance in the 
offspring and an increased risk of neurodevelopmental disorders including cerebral palsy. 
Preliminary evidence suggests potential implications for immune and infectious disease 
related outcomes. Insights from experimental studies support causal effects of maternal 
obesity on offspring outcomes, mediated at least in part through changes in epigenetic 
processes including alternations in DNA methylation, and perhaps through alterations in the 
gut microbiome. Although the offspring of obese women who lose weight prior to pregnancy 
have a reduced risk of obesity, to date few controlled intervention studies have reversed 
maternal obesity and examined the consequences for the offspring. The long term effects of 
maternal obesity may have profound public health implications and indicate the urgency of 
studies on causality, underlying mechanisms and effective interventions to reverse the 
epidemic of obesity in women of child-bearing age and to mitigate its consequences for the 
offspring.   
 
 
  
Introduction 
Maternal obesity is widely recognised for its immediate implications in terms of pregnancy 
complications, including gestational diabetes, pre-eclampsia and delivery of large-for-
gestational infants.1 More recently the recognition that developmental influences can have 
long term consequences on offspring health and wellbeing has focused attention on the 
potential for maternal obesity to be one of the influences contributing to the “developmental 
origins of health and disease”.2 The high prevalence of maternal obesity associated with the 
global obesity epidemic dictates that determination of any such long-term effects is now an 
urgent priority.3  
 
While control for potentially confounding variables remains a challenge in human 
observational studies, an extensive experimental literature in rodents and non-human 
primates has demonstrated that maternal obesity induced by dietary intervention leads to 
obesity, diabetes, raised blood pressure, fatty liver and behaviour changes in the offspring.4 
Maternal obesity has been shown to permanently alter a variety of metabolic control 
processes in the fetus, including the hypothalamic response to leptin and subsequent 
regulation of appetite and pancreatic beta cell physiology.4 Mechanisms are likely 
multifactorial but potentially include maternal metabolic changes such as changes in 
glucose and fatty acids,5 altered  maternal hypothalamic-pituitary-adrenal axis activity6 and 
changes in placental function and inflammation.7  
 
In this Series paper, we review the evidence linking maternal obesity with long-term 
offspring consequences, focusing on body composition, cardiometabolic, allergic, 
immune/infectious and neuro-behavioural outcomes and discuss altered epigenetic 
processes as a likely major mechanism underlying long-term effects of maternal obesity on 
the offspring.  
 
Body composition and cardiometabolic outcomes  
An accumulating body of evidence suggests that maternal pre-pregnancy obesity and 
excessive gestational weight gain are associated with an increased risk of obesity in the 
offspring during childhood.8-11 While the initial focus was on extreme categories of maternal 
obesity, several recent studies suggest that higher maternal pre-pregnancy body mass 
index (BMI) across the full spectrum is associated with greater childhood adiposity and an 
adverse body fat distribution.12-15 Higher gestational weight gain is also associated with a 
higher childhood BMI and greater fat mass estimated by dual-energy X-ray 
absorptiometry.15-20 Whilst both maternal pre-pregnancy obesity and excessive gestational 
weight gain seem to be associated with a higher blood pressure, adverse lipid profile, and 
insulin resistance in childhood,12,16,20,21 there is some evidence that these associations are 
largely mediated by childhood BMI.12,16  
 
Alongside studies focused on outcomes in children, multiple studies have suggested that a 
higher maternal pre-pregnancy BMI and greater gestational weight gain are associated with 
a higher BMI in adolescents and adults.22-29 A study of 2,432 Australians found that greater 
maternal gestational weight gain was associated with a higher BMI (on average 0.3 kg/m2 
(95% CI 0.1-0.4 kg/m2) higher for each 0.1 kg/week greater gestational weight gain)  in the 
offspring at the age 21 years.29  These associations were independent of maternal pre-
pregnancy BMI. Similarly, a study among 1400 mother-offspring pairs in Jerusalem showed 
that higher maternal pre-pregnancy BMI was associated with higher offspring BMI at age 30 
years (an increase of 1.8kg/m2 in offspring BMI per increase of one standard deviation in 
maternal pre-pregnancy BMI).23 In this study the associations of maternal pre-pregnancy 
BMI with cardiovascular risk were fully explained by adult BMI.23 Findings from the Helsinki 
Birth Cohort Study (HBCS) suggest that maternal BMI is positively associated with offspring 
BMI at age 60 years.30,31 A higher maternal BMI was also associated with a less favourable 
body fat distribution in female offspring at a mean age of 62 years.31 Similarly to the studies 
in children, no consistent associations of maternal BMI with other cardiovascular risk factors 
were present among adults. Inconsistencies may be due to study design and availability of 
measurements and confounding factors. 
 
Findings from registration/register-based and retrospective cohort studies in Helsinki 
implicate maternal obesity in pregnancy as an important determinant of the risk of 
cardiovascular morbidity and mortality in the offspring. A further study using birth records 
from 37,709 individuals in the UK showed that a higher maternal BMI was associated with 
an increased risk of premature all-cause mortality (hazard ratio HR 1.35, 95% CI 1.17-1.55) 
and hospital admissions for cardiovascular events in adult offspring (HR 1.29, 95% CI 1.06-
1.57).32 These associations were independent of socioeconomic status and current age. In 
line with these findings, similar findings have been reported in the Helsinki Birth Cohort 
Study participants born 1934–44 and followed up between the years 1971 to 2010.33 
Cardiovascular disease, coronary heart disease, type 2 diabetes and stroke were all more 
common among offspring of obese mothers. For cardiovascular disease, findings were 
similar for males and females, while for type 2 diabetes the association was stronger in 
women. The association of maternal BMI with offspring coronary heart disease was 
statistically significant among males only (trend per kg/m2 HR 1.031, 95% CI 1.009-1.054), 
whereas the association of maternal BMI with stroke was significant among females only 
(trend per kg/m2 HR 1.059, 95% CI 1.019-1.101).33  
 Several studies have aimed to identify critical periods of maternal weight during pregnancy 
for childhood outcomes. A study performed among 5,000 UK mother-offspring pairs showed 
that gestational weight gain in the first 14 weeks of pregnancy was positively associated 
with offspring adiposity at 9 years of age.17 Likewise a study among 6,000 Dutch mother-
offspring dyads showed that early-pregnancy weight gain was associated with an adverse 
cardio-metabolic profile (OR 1.20 95% CI 1.07- 1.35) in childhood16 and that this finding 
was independent of maternal weight gain before pregnancy and of weight gain in later 
pregnancy. These studies suggest that maternal weight gain in early pregnancy, when 
maternal fat accumulation forms a relatively large component of gestational weight gain,34 
may be a critical period for an adverse childhood cardiovascular risk profile. 
 
Thus, maternal pre-pregnancy obesity and gestational weight gain, especially in early 
pregnancy, may influence the risks of adiposity and adverse cardiovascular risk from 
childhood to adulthood.  
 
 
Allergic and atopic outcomes  
The global rise in maternal obesity has been implicated in the parallel rising burden of 
asthma, allergic disease and other early immune diseases, with speculation that this may 
be part of the multisystem consequences of obesity-related inflammation for the offspring.  
Indeed, a recent meta-analysis that included 14 studies and 108,321 mother-child pairs 
found that maternal overweight or obesity in pregnancy were associated with increased 
risks of childhood asthma or wheeze ever (OR 1.31, 95%CI 1.16-1.49) and current asthma 
or wheeze (OR 1.21; 95%CI, 1.07-1.37), independent of offspring BMI.35 Higher maternal 
gestational weight gain was also associated with higher offspring odds of current asthma or 
wheeze (OR 1.015 per 1 kg increase, 95% CI 1.01–1.02) but not associated with asthma or 
wheeze ever (OR = 1.04 per kg, 95% CI 0.97–1.11). Follow up of the Danish National Birth 
Cohort found that the impact of maternal obesity was largely limited to asthma and 
wheezing, and did not increase the risk of eczema, sensitisation (largely assessed to 
aeroallergens) or hay fever,36 suggesting tissue specific effects. This is consistent with 
evidence that allergic diseases result from both systemic immune dysregulation and tissue-
specific effects during critical stages of development.  
 
Whilst pathways linking maternal obesity to offspring allergic and atopic outcomes are 
multifactorial, the contribution of reduced microbial diversity, and in particular intestinal 
dysbiosis, has emerged as a central risk factor. Changing microbial exposure has been 
long implicated in the dramatic increase in early-onset inflammatory non-communicable 
disease such as allergy and asthma, but the importance of these complex microbiological 
ecosystems is becoming increasingly apparent in the physiological, immunological, and 
metabolic dysregulation seen in obesity.37 Emerging evidence suggests the multisystem 
influences of declining microbial diversity also begin in utero, including through epigenetic 
influences.38 
 
Thus, an aberrant gut microbiome, known to be associated with maternal obesity, provides 
an additional mechanism for both the immune and metabolic consequences on the 
developing fetus.39 There is preliminary evidence in humans that dietary manipulation of the 
maternal microbiome in pregnancy with prebiotic fibre has beneficial effects for both 
offspring immune function and metabolism (reviewed in [40]). In animal models this can 
prevent the development of an allergic asthma phenotype in the offspring – an effect 
directly mediated by the short chain fatty acid (SCFA) metabolites produced by microbial 
fermentation of dietary fibre.41 In addition to their effects on metabolism, glucose 
homeostasis and appetite regulation, SCFA also have powerful anti-inflammatory effects – 
both in local tissues and systemically through regulatory T cell induction.40,41 Notably, this 
includes tissue-specific effects in the lung. Moreover, there is preliminary evidence in 
humans that high SCFA (acetate) levels in pregnancy correlates with fewer doctor visits for 
cough and wheeze in their offspring.41 This provides a novel perspective on how a Western-
style fast food diet associated with obesity might increase asthma risk, whereas a 
Mediterranean diet (high in fish, fruits, nuts and vegetables) might be protective against 
wheeze and asthma in childhood42; such an effect could be mediated, at least in part, 
through the microbiome and its metabolic effects on immune responses and tissue function. 
 
Collectively these observations underscore the complex interplay between evolving 
metabolic and immune responses and how these may be modified by maternal nutrition, 
adiposity and microbial diversity to alter susceptibility to inflammatory diseases across the 
lifecourse.43  
 
Other immune and infectious disease related outcomes  
Whether maternal obesity increases offspring susceptibility to other immune and infectious 
disease related outcomes has been less well studied, but is important to consider given the 
rising increases in obesity in low- and middle-income countries44 where the burden of 
infection during pregnancy and in childhood is high. With dampened maternal immunity to 
tolerate the semi-allogenic offspring, pregnancy represents a period of increased 
susceptibility to infection, and maternal obesity further increases this risk.45 Studies in 
rodent models of maternal obesity demonstrate worse offspring outcomes in response to 
bacterial infection and experimentally induced autoimmunity.46,47  
 
In humans, maternal obesity also impacts the maturation and development of the newborn 
immune system, with adverse influences on the frequency and function of key innate and 
adaptive immune cells measured in umbilical cord blood.48  Infants born in developed 
countries also have different proportions of circulating immune cells and innate immune 
responses compared to those born in developing countries, but at present little is known 
about the contributions of maternal nutritional state vs. other exposures (e.g. infections) to 
these differences.49 The difference may, however, have important effects on susceptibility 
to pathogens, responses to vaccines, and development of immunopathological disorders 
such as asthma and allergy.50 Obesity is a recently recognised risk factor for severe viral 
infections,51 and in obese mothers prenatal exposure to a range of infections (such as 
influenza, Toxoplasma gondii, rubella, cytomegalovirus and herpes simplex virus) could 
have consequences for the offspring, including cardiometabolic and neurobehavioural 
diseases. It is not known if maternal obesity further increases susceptibility to vertical 
transmission of pathogens, though it is plausible that this may occur indirectly through 
exacerbation of the already altered maternal endocrine, immune, metabolic milieu and 
inflammatory status associated with maternal adiposity.52,53  
 
A further important consideration is whether therapies used to treat maternal infection can 
also have adverse impacts on the offspring’s risk of later disease, through increasing 
maternal adiposity. Notably protease inhibitors, antiretrovirals (ARVs) used to prevent 
mother-to-child transmission of HIV, are associated with adverse maternal metabolic side 
effects. These include changes in maternal body composition including increased central 
adiposity, together with associated dyslipidaemia, insulin resistance, type 2 diabetes and 
mitochondrial toxicity which may have long term effects on ARV-exposed infants.54 Detailed 
studies will be required to establish the long term effects, and to determine optimal 
regimens to reduce any adverse outcomes. 
 
Offspring neurocognitive and behavioural outcomes  
Despite the potential public health importance, relatively few cohort studies have examined 
associations between maternal obesity and detailed neuro-developmental outcomes in 
offspring (Table 1). For cognitive outcomes, human data showed that higher pre-pregnancy 
weight is associated with poorer cognitive outcomes, while higher (but not excessive) 
weight gain during pregnancy has been associated with better offspring cognitive 
outcomes.55,56 However, published data do not allow definitive conclusions of potential 
effects of pre-pregnancy adiposity on offspring cognitive development. Most studies found 
modest inverse associations with both early and later cognitive standardized assessments 
or reading and math scores,57 while a recent study found indications for a possible 
temporary increase in cognitive outcomes on a standardized assessment at 6 months.58 
However, associations with maternal reports of cognitive performance were inconsistent in 
other large cohort studies.59  
 
Maternal obesity has also been associated with offspring behavioural and emotional 
problems.57,60 A recent meta-analysis and longitudinal study found an increased risk for 
Autism Spectrum Disorders in children of mothers with obesity before/during pregnancy or 
excessive gestational weight gain,60,61 with other approaches suggesting a particularly 
robust association for excessive gestational weight gain .62 In 3 large European cohort 
studies the association between pre-pregnant obesity and Attention Deficit Hyperactivity 
Disorder was inconsistent, and lost when adjusted in full sibling comparisons.59,63 Fewer 
studies have investigated the association with affective disorders and no recent studies 
have investigated the link with anxiety, psychotic or eating disorders. Only one qualitative 
review has been published on pre-pregnancy obesity and schizophrenia, which suggested 
an association, although maternal schizophrenia was not taken into account.64  Although 
past studies reported contradictory results relating maternal obesity to offspring cerebral 
palsy,65 large studies over the last 5 years have found positive associations, even after 
multiple adjustments.57   
 
One major limitation of the above-mentioned studies is the difficulty in differentiating 
intrauterine effects from residual confounding. One way to explore this is to compare effect 
sizes of maternal obesity versus paternal obesity. However, even with maternal effect sizes, 
it is clear that other influences are also associated with both obesity and 
neurodevelopment, such as maternal intelligence, socio-economic status, breastfeeding, 
maternal mental health, maternal diet and other postnatal lifestyle influences. Other 
reasons for contradictory findings are differences in methodology, sampling biases, different 
ages of measuring outcomes and differences in defining obesity and outcomes. Some 
studies used retrospective self-reports of pre-pregnancy weight or maternal reports of 
offspring outcomes, which may be less reliable.55,59  
 
In human studies it is difficult to confirm causation or to identify mechanisms linking 
maternal obesity with offspring neurodevelopment. However, studies in rodents and non-
human primates have indicated 3 potential pathways: 1) high levels of nutrients, including 
fatty acids and glucose; 2) high levels of hormones like leptin and insulin; 3) inflammatory 
mediators, including interleukins and tumor necrosis factor.57,66 These factors cross the 
placenta and can influence fetal neuroendocrine development, neuronal proliferation and 
brain development.57,66 Many dynamic factors play a role, with complex interactions 
between maternal environment, placental patho-physiology and fetal epigenetic changes. 
Indeed, animal studies showed that obesity during pregnancy can change brain 
homeostasis and offspring behaviour through epigenetic mechanisms, including in the 
serotonin and dopamine pathways, lipid peroxidation and corticosteroid receptor 
expression.67,68 Even parental lifestyle factors prior to and at conception may have 
transgenerational effects by epigenetic reprogramming at fertilization.69  
 
 
Maternal obesity has many pathophysiological features in common with gestational 
diabetes, a condition increasingly associated with evidence of mild cognitive impairment in 
the offspring.58 For maternal obesity the paucity of current evidence indicates a need for 
large-scale studies with more detailed cognitive and behavioural phenotyping in populations 
of different cultures and ethnicities. Future studies should examine if maternal diet or 
obesity itself is more important for programming of neurodevelopmental outcomes, and 
include comprehensive assessments of diet and direct measurements of adiposity. 
Moreover, underlying mechanisms should be studied in humans with biomarkers including 
genetic and epigenetic modifications.  
 
Epigenetic modifications: a potential underlying mechanism  
Epigenetic processes are emerging as an important mechanism through which the 
“memory” of developmental exposures is held, with pathophysiological consequences for a 
variety of organs and systems. Epigenetic modifications have been proposed as a key 
causal mechanism linking maternal adiposity and offspring outcome.70 Moreover, there is 
now emerging evidence that epigenetic processes can act over several generations, 
including three or more generations and through the paternal line.71 Epigenetic 
modifications result in alterations in gene function in the absence of changes in the DNA 
sequence. The epigenetic marks which mediate this include DNA methylation, post-
translational modification of histones and non-coding RNAs. DNA methylation occurring 
predominantly at cytosines in cytosine-guanine (CpG) dinucleotides is the most widely 
studied. Table 2 summarises the existing evidence linking maternal obesity in humans with 
offspring DNA methylation.  
As shown in Table 2, a number of studies have used global methylation techniques to 
explore associations between maternal obesity and offspring DNA methylation. Though the 
findings are not consistent, three cohort studies found associations between maternal BMI 
and offspring DNA methylation at birth72,73 and at 3 years.74 Notably, in the largest and 
methodologically most robust study73 the methylation differences were only observed with 
comparisons of extreme groups of BMI (i.e. obese vs normal-weight) and not when the 
over-weight group was compared with normal-weight group. Reasons are unknown but this 
observation may partly explain the negative findings in other studies where analyses have 
been conducted across a range of maternal BMI measurements.75,76 The observation of 
differentially methylated CpG sites in the peripheral blood of 2-25 year old siblings born to 
obese mothers before and after bariatric surgery with associated weight loss77 is also 
consistent with the hypothesis that maternal obesity impacts on offspring DNA methylation.  
 
Where a candidate gene approach has been adopted, associations between maternal 
adiposity and DNA methylation at imprinted genes78-80 or in a number of genes known to be 
involved in metabolism78-82 have been reported. Of particular interest is the observation that 
aryl-hydrocarbon receptor repressor (AHRR) DNA methylation is 2.1% higher in offspring of 
obese vs. normal weight mothers81; robust links are now established between maternal 
smoking and offspring AHRR methylation and there is much evidence that maternal 
smoking is associated with long term effects on offspring adiposity.15 The observations 
raise the possibility that AHRR DNA methylation may be involved in the link between 
maternal obesity and offspring adiposity. There is also evidence that maternal glycaemia is 
involved in causal pathways influencing offspring leptin epigenetic regulation.83  
 
Methodological considerations 
Fixed genetic variants shared by mother and offspring are important confounders of 
proposed links between metabolic factors linked to maternal obesity and offspring 
outcomes, as are shared postnatal influences on diet/lifestyle behaviours84 and 
microbiome-related mechanisms.85 However, abdominal fat depots already differ at birth 
between groups with different risks of later metabolic disease86 and it seems likely that at 
least some of the effects of maternal obesity are mediated through prenatal environmental 
mechanisms. Further delineation of maternal effect modifiers will aid the development of 
interventions to improve offspring health, as will understanding of the underlying 
mechanisms and related biomarker signatures of these processes.  Alongside giving 
insights into the fundamental processes and additional risk factors, such signatures will 
provide immediate outcome/adherence measures for interventions, and enable 
identification of postnatal effect modifiers and stratification of infants for targeting of 
postnatal interventions. 
 
Whilst the available data is consistent with the hypothesis that maternal obesity impacts on 
offspring DNA methylation changes at birth, whether these changes impact on development 
of later adverse outcomes in the offspring remains unclear. The observation that the 
methylation changes found at birth were also present at 3 year follow-up,74 provides some 
evidence that the methylation changes may persist over time. This, together with the 
observation of persistence of epigenetic marks associated with obesity across childhood 
and adolescence,87 raises the possibility that epigenetic analysis may provide useful 
biomarkers of disease risk across the lifespan. The findings do need to be interpreted with 
caution. Few studies have included attempts to replicate or validate findings through using 
a replication cohort,76 validation in comparison with published data73 or sex specificity. It is 
well established that many DNA methylation patterns are tissue- and cell- specific,88 so the 
relevance of findings from DNA extracted from cord or peripheral blood leukocytes remains 
unclear. However, there is also evidence that, for a number of non-imprinted genes, DNA 
methylation levels measured in blood are equivalent in buccal cells despite the fact that 
these cell types arise from different germ layers (mesoderm and ectoderm respectively).89  
 
Whilst the majority of studies have utilised DNA extracted from blood leukocytes as a 
window on processes occurring in the fetus,72-76,78-81 the heterogeneity in sample 
population, study size, and the inconsistency between methodological approaches, makes 
comparison of studies challenging. Further, methodological considerations, particularly if 
complex tissues are used such as the placenta which contains mixed cell types, each with a 
distinct methylation pattern, may present problems with data interpretation. 
 
We do not know whether the reported associations between maternal obesity and 
epigenetic processes are causal in relation to later outcomes, or whether they are merely a 
response to the maternal obesogenic environment, or are secondary to the changes in 
growth that occur in a fetus exposed to maternal obesity in utero. Obesity is also associated 
with changes in intestinal microbiota and epigenetic changes can also be induced by gut 
microbiome metabolites such as short chain fatty acids. Obesity associated changes in 
intestinal microbiota have implications for infant microbiome development with 
consequences for later child outcomes.90  Postnatal colonization of the microbiome in 
offspring has been linked to changes of the hypothalamic-pituitary-adrenal axis linking brain 
function and intestinal bacteria.91 Studies indeed showed associations between changes in 
the microbiome and neurodevelopment disorders in which inflammation is implicated, such 
as autism-spectrum disorders and attention-deficit hypersensitivity disorder.92  
 
Studies to test causality for effects of maternal obesity on offspring epigenetics in humans 
are hard to conduct; however, utilising associations with paternal obesity as a ‘negative 
control’, the demonstration that epigenetic modifications are more strongly associated with 
maternal than paternal obesity73 provides some support for the thesis that the associations 
of maternal obesity with offspring methylation are due to an intrauterine mechanism. The 
experimental demonstration that paternal diet prior to conception can have lasting effects 
on offspring outcomes through epigenetic processes does, however, add further complexity 
to an already complex situation.69 Further, many of the techniques used to investigate 
global DNA methylation changes are limited in coverage of the human epigenome. For 
example, the Infinium HumanMethylation450 BeadChip array used in many recent 
studies73,77 only covers around 1.7% of all CpG sites in the genome and to date there has 
been little consideration of non-CpG methylation or 5-hydroxymethylation.93 More studies 
are needed that consider interaction of epigenetic changes with changes in the genome – 
recent studies suggest that around a quarter of the variation in neonatal methylomes arises 
from fixed genetic variants, with the remainder from gene-environment interactions.94   
 Conclusion  
Although initial research linking developmental influences with major non-communicable 
disorders in later life focused on the effects of fetal undernutrition, increasing evidence 
indicates that exposure to maternal obesity also leads to an increased risk of disease in the 
offspring. Observational studies have provided strong evidence for associations between 
maternal obesity and an increase in the offspring’s risk of obesity, coronary heart disease, 
stroke, type 2 diabetes and asthma. Emerging evidence suggests that maternal obesity 
may be associated with poorer cognition in the offspring and an increased risk of 
neurodevelopmental disorders including cerebral palsy. With the exception of recent small 
studies of obese women who had bariatric surgery between pregnancies, there is a paucity 
of controlled intervention studies that have reversed maternal obesity and examined the 
consequences for the offspring. However, the offspring of obese women who lose weight 
prior to pregnancy have reduced risk of obesity95, and insights from experimental studies 
support a causal effect of maternal obesity on offspring outcomes in later life. Mechanistic 
insights also support causal effects on maternal obesity on the offspring, mediated through 
changes in epigenetic processes, and perhaps through alterations in the gut microbiome of 
the offspring. Table 3 lists key points for further research. 
 
Greater insight is needed into the mechanisms acting in the mother, through which 
maternal obesity and excess nutrient supply impart increased risk for future metabolic 
disease. Pre-pregnancy obesity predisposes the mother to gestational diabetes, 
hypertension and pre-eclampsia which may affect placental function and fetal energy 
metabolism. In addition, obesity in pregnancy is associated with complex neuroendocrine, 
metabolic and immune/inflammatory changes which likely impact on fetal hormonal 
exposure and nutrient supply.6,96 
 
The observations linking maternal obesity with lifelong consequences for the offspring have 
profound public health implications.  The prevalence of overweight/obesity in women of 
childbearing age is increasing worldwide (with over 60% of women either overweight or 
obese at conception in the United States97), which will increase population of children 
exposed to an “obese intrauterine environment” and thus perpetuate cycle of increasing 
obesity and chronic disease burden. Public health measures that will rapidly reverse the 
current epidemic of maternal obesity appear implausible at present; in their absence, 
breaking the cycle of maternal and offspring obesity requires from a new generation of 
intervention studies, based on more detailed analysis of observational studies and designed 
with a better understanding of the underpinning mechanisms acting in the mother and 
offspring. 
 
Search strategy  
In this section we systematically reviewed studies with MEDLINE (1980-2015, EMBASE 
(1980-2015) and Cochrane library (1980-2015) with the search terms “maternal obesity”, 
“pre-conception”, “pregnancy”, “intergenerational”, “offspring” or “infant” or “child” in 
combination with the terms “fetal programming”, “epigenetic”, “methylation”, “disease”, 
“immunity”,  “cardiovascular”, “type 2 diabetes”, “infection”, “HIV”, “malaria”, 
“proinflammatory”, “cognition”, “school performance”, “psychopathology”, “mental health”, 
“ADHD”, “autism”, “affective disorders”, “anxiety disorders”, “eating disorders”, “psychotic 
disorders” and “cerebral palsy”. We selected large cohort and case-control studies that 
were judged relevant, with a focus on studies conducted over the last 10 years in humans, 
but not excluding commonly referenced and highly regarded older publications. We also 
included references of articles identified by our search strategy and included those that 
were found relevant.  
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Table 1. Studies linking maternal obesity with offspring asthma   
 
Study Population Sample Size 
& Age 
Country Major Findings 
Dumas, et al.  
Allergy 2016 – in press 
Analyses of children of 
participants in the Nurses' 
Health Study II. Physician-
diagnosed asthma and 
allergies were assessed by 
questionnaires. 
n=12,963 
children aged 
9-14 years 
USA Maternal pre-pregnancy overweight (OR: 1.19, 
95% CI: 1.03-1.38) and obesity (1.34, 1.08-1.68) 
associated with asthma in offspring.  
Gestational weight gains (GWG) of <15 lb and 
higher risk of offspring asthma (1.28, 0.98-1.66) 
Pike, et al.  
Thorax 2013; 68: 372-379. 
Mothers and children from the 
Southampton Women’s 
Survey. Childhood follow-up 
visits occurred at 6, 12, 24 
and 36 months. Skin prick 
tests at 6 years.  
n=940 
children with 
data in the 
first 6 years 
UK Greater maternal BMI and fat mass associated 
with increased transient wheeze (relative risk 
(RR) 1.08 per 5 kg/m2, p=0.006; RR 1.09 per 10 
kg, p=0.003), but not with persistent wheeze or 
asthma. Maternal adiposity not associated with 
offspring atopy, exhaled nitric oxide. 
Guerra, et al.  
Paediatr Perinat Epidemiol 2013;27: 
100-108. 
Multicentre longitudinal 
population-based study using 
two INMA birth cohorts in 
Sabadell/Gipuzkoa. Wheeze 
data obtained through 
interviewer-administered 
parental questionnaires. 
n=1107 
mother–child 
pairs 
assessed up 
to 14 months 
 
Spain Maternal prepregnancy obesity increased risk of 
frequent [RR 4.18, 95% CI 1.55, 11.3] but not 
infrequent (RR 1.05 [95% CI 0.55, 2.01]) 
wheezing in their children. Children of obese 
mothers more likely to have frequent wheezing 
than children of normal-weight mothers (11.8% 
vs. 3.8%; P = 0.002). 
Harpsoe, et al.  
J Allergy Clin Immunol 
2013;131:1033-1040. 
Mother-child pairs from the 
Danish National Birth Cohort  
with information from the 16th 
week of pregnancy and at age 
6 months, 18 months, and 7 
years of the child 
n=38,874 
mother-child 
pairs 
assessed up 
to 14 months 
Denmark Maternal prepregnant BMI>/=35 (adjusted OR, 
1.87; 95% CI, 0.95-3.68) and GWG>/=25 kg 
(adjusted OR, 1.97; 95% CI, 1.38-2.83) were 
associated with current severe asthma at age 7 
years. Maternal BMI and GWG were not 
associated with eczema or hay fever. 
Watson, et al. 
Maternal Child Health 2013; 17: 959-
967. 
Prospective study of 
European & Polynesians from 
northern New Zealand. Home 
assessments in pregnancy & 
age 18 months. 
n = 369 
18 month old 
infants 
New Zealand Changes in subcutaneous fat during pregnancy 
are associated with prevalence of infant wheeze. 
Wheeze prevalence was 19.2% where the 
difference in mothers' skinfolds between months 
4 and 7 decreased by ≥10 mm and 41.7% where 
the difference increased by ≥10 mm.   
Patel, et al.  
J Epidemiol Community Health 
2012;66: 809-814. 
Adolescents born within the 
prospective 1986 Northern 
Finland Birth Cohort 
n=6945 
adolescents 
assessed for 
asthma 
symptoms 
age 15-16 yrs 
Finland High maternal pre-pregnancy BMI was a 
significant predictor of wheeze in the adolescents 
(increase per kilogram per square metre unit; 
2.8%, 95% CI 0.5 to 5.1 for wheeze ever; and 
4.7%, 95% CI 1.9 to 7.7 for current wheeze). 
Lowe, et al.  
J Allergy Clin Immunol 2011;128: 
1107-1109. 
 
Data linkage of Swedish 
national registers: Swedish 
Medical Birth Registry, 
Swedish Prescribed Drug 
Register and Swedish 
Inpatient Registry. Asthma 
medication use from ages 6 to 
8 years and 8 to 10 years 
n=89,783 
children born 
to 129,239 
mothers in 
Stockholm 
between 1998 
and 2009.  
Sweden Higher maternal BMI was consistently associated 
with an increased risk of asthma in the child, both 
in terms of medicine use and hospitalization. 
Risk of asthma medication use increased for 
Maternal BMI of 30-34.9 (OR: 1.40, 95% CI: 
1.16-1.68) and Maternal BMI of >35 (OR: 1.57, 
95% CI: 1.15-2.15) 
Scholtens, et al. 
Int J Obes 2010; 34: 606-613. 
Birth cohort participating in 
the Prevention and Incidence 
of Asthma and Mite Allergy 
(PIAMA) study, with 
sensitization and bronchial 
hyperresponsiveness 
determined at 8 years 
 n=3963 
children and 
their mothers  
Netherlands Maternal overweight before pregnancy increased 
risk of childhood asthma at 8 years (OR=1.52, 
95% CI: 1.05-2.18) in children with atopic 
heredity. No association was observed in 
children without a predisposition (OR=0.86, 95% 
CI: 0.60-1.23). There was no association with 
sensitization or BHR. 
Kumar, et al.  
Pediatr Allergy Immunol Pulmonol 
2010;23: 183-190. 
Boston Birth Cohort (started in 
1998) followed prospectively 
to a mean age of 3.0 +/- 2.4 
years with study visits aligned 
with the pediatric primary care 
schedule. 
n=1,191 
children 
USA Children of obese mothers had an increased risk 
of recurrent wheezing (OR, 95% confidence 
interval: 3.51, 1.68-7.32). In contrast, maternal 
obesity was not associated with eczema or food 
allergy 
Haberg, et al.  
Paediatr Perinat Epidemiol 2009;23: 
352-362. 
Population-based cohort 
study: Norwegian Mother and 
Child Study (MoBa). 
n=33,192 
children, born 
between 1999 
and 2005 
Norway The risk of wheeze increased linearly with 
maternal BMI in pregnancy, and was 3.3% higher 
[95% CI 1.2, 5.3] for children with mothers who 
were obese during pregnancy, than for children 
of mothers with normal BMI. 
Reichman, et al.  
Matern Child Health 2008 12: 725-
733. 
Population-based sample of 
children born in large U.S. 
cities in 1998-2000. Main 
outcome: maternal reported 
diagnosis of asthma in child 
by 3 years.  
n=1971 USA Children with obese mothers had 52% higher 
odds of having an asthma diagnosis by age 3 
(OR=1.52; 95% CI: 1.18-1.93). 
  
Table 2. Studies reporting the odds ratios of neurodevelopment disorders in offspring for women with overweight or obesity before or during 
pregnancy.  Only studies over the last 6 years, with reported odds ratios have been included. 
 
Studies using global methylation techniques 
Study Population Design Country Age  Overweight/obesity 
mother 
Odds ratios of Neurodevelopment 
Disorders 
Brion, et al. 
Pediatrics 
2011;127:e202-211. 
 
British Avon 
Longitudinal Study UK 
and Generation R 
study in the 
Netherlands 
 
n=5000 (UK) and 
n=2500 (the 
Netherlands) 
Cohorts The 
Netherlands 
and the UK 
Behavioral 
problems, e.g. 
attention deficit 
measured at 47 
months (UK) 
and 36 months 
(Netherlands) 
by parental 
reports 
Maternal pre-
pregnancy 
overweight 
(25≤BMI<30) 
Maternal pre-pregnancy overweight 
was not associated with an increased 
risk of attention deficit problems (or 
other emotional problems and 
internalizing problems) found in both 
cohorts. 
Chen, et al. 
Int J Epidemiol 2014; 
43: 83-90. 
 
 
Population based 
cohort study with data 
of national and 
regional registers 
 
n=673,632 with n = 
272,790 full biological 
siblings  
Cohort Sweden From age 3 
until diagnosis 
of ADHD, death 
or emigration 
Pre-pregnancy 
overweight  
(25≤BMI<30) and 
pre-pregnancy 
obesity 
(BMI ≥30)    
Pre-pregnancy overweight 
associated with OR = 1.23, (95% CI 
= 1.18-1.27) increase in Attention 
Deficit Hyperactivity Disorder & OR = 
0.98 (95% CI = 0.83-1.16) non-
significant increase in full sibling 
comparisons. 
Pre-pregnancy obesity associated 
with OR 1.64 (95% CI = 1.57-1.73) 
increase in ADHD & OR 1.15 (95% 
CI = 0.85-1.56) non-significant 
increase in full sibling comparisons 
for ADHD. 
Crisham, et al. 
J Pediatrics 2013; 
163: 1307-1312. 
 
 
Longitudinal 
population based 
study  
 
n = 6,221,001 with 
8798 diagnoses of 
Cerebral Palsy   
Cohort USA Newborns 
followed up 
until age 5 for 
Cerebral Palsy 
assessment 
Pre-pregnancy 
obesity  
(BMI >=30) and pre-
pregnancy morbid 
obesity  
(BMI ≥40)  
Pre-pregnancy obesity was 
associated with OR 1.72 (95% CI 
1.25-2.35) increase in Cerebral 
Palsy. 
Pre-pregnancy morbid obesity was 
associated with OR 3.79 (95% Ci 
2.35-6.10) increase in Cerebral 
Palsy. 
Gardner, et al. 
Int J Epidemiol 2015; 
44: 870-883. 
Stockholm Youth 
Cohort, population-
based study 
 
Cohort Sweden 4 years to 21 
years 
Pre-pregnancy 
overweight  
(25≤BMI<30) and 
pre-pregnancy 
Pre-pregnancy overweight was 
associated with OR 1.31 (95% CI 
1.21-1.41) increase in Autism 
Spectrum Disorders. 
 n = 333,057 with 6,420 
Autism Spectrum 
Disorder cases and 
1,156 matched 
siblings 
obesity 
(BMI ≥30) and 
Excessive 
gestational weight 
gain (according to 
the Institute of 
Medicine) 
Pre-pregnancy obesity was 
associated with OR 1.94 (95% CI 
1.72-2.17) increase in Autism 
Spectrum Disorders.  
Excessive gestational weight gain 
was associated with OR 1.48 (95% 
CI 0.93-2.38) non significant increase 
in Autism Spectrum Disorders in 
matched sibling analyses. 
Jo, et al. 
Pediatrics 2015; 
135: e1198-1209. 
Infant Feeding 
Practices Study II, a 
US national distributed 
longitudinal study 
 
 
n = 1311 
Cohort USA 6 years Severe pre-
pregnancy obesity 
(BMI >35.0) 
Severe pre-pregnancy obesity was 
associated with OR 3.13 (95% CI, 
1.10-8.94) increase in Autism 
Spectrum Disorders/development 
delay disorders diagnosis and with 
OR 4.55 (95% CI, 1.80-11.46) 
increase in ADHD by maternal report. 
Li, et al. 
J Autism Devel 
Disorders 2016; 46: 
95-102 
 
Meta-analysis of 4 
population-based and 
1 case-cohort study 
 
n =129,733 with 924 
Autism Spectrum 
Disorder cases 
(Canada);  n = 517 
with 315 Autism 
Spectrum Disorder  
cases (USA);  n = 
4800 with 100 Autism 
Spectrum Disorder 
cases (USA);  n = 
92,909 with 419 
Autism Spectrum 
Disorder cases 
(Norway);   n = 62 with 
14 ASD cases (USA 
case-control study) 
4 
population-
based 
cohort and 
one case-
cohort 
study 
1 from 
Canada, 3 
from USA, 
and 1 from 
Norway 
 
1-17 years 
(Canada) 
4-5 years 
(USA) 
2 years (USA) 
4-13.1 years 
(Norway) 
2-5 years 
(USA, case-
control study) 
 
Pre-pregnancy 
obesity and obesity 
during pregnancy 
(BMI ≥30 or pre-
pregnancy weight 
≥90 kg) 
Pre-pregnancy and pregnancy 
obesity was associated with a pooled 
adjusted OR 1.47 (95% CI 1.24-1.74) 
increase in Autism Spectrum 
Disorders. 
Pan, et al. 
J Child Neurol 2014; 
29: NP196-201. 
 
South Carolina 
Medicaid program, a 
retrospective study 
 
n=83,901 with 100 
cases of any Cerebral 
Palsy and 53 cases of 
confirmed Cerebral 
Palsy (at least 2 
diagnoses) 
Cohort USA 5 - 8 years Severe obesity at 
birth (35≤BMI<40) 
and morbid obesity 
at birth (BMI ≥40) 
 
Severe obesity was associated with 
OR 2.00 (95% CI 1.00 – 4.01) 
increase with any Cerebral Palsy and 
OR 1.22 (CI 0.38-3.81) with 
confirmed Cerebral Palsy. 
Morbid obesity was associated with  
OR 2.95 (95% CI 1.45-5.97) increase 
in any Cerebral Palsy and OR 3.03 
(CI 1.09-8.37) with confirmed 
Cerebral Palsy. 
Roderiquez, et al. 
J Child Psychol 
Psychiatr 2010; 51: 
134-143. 
Population-based 
prospective 
pregnancy-offspring 
study  
 
n =1714 
cohort Sweden 5 years Pre-pregnancy 
overweight 
(25≤BMI<30) and 
Pre-pregnancy 
obesity 
(BMI ≥30)    
Pre-pregnancy overweight was 
associated with OR 1.92 (95% CI 
1.21-3.05) significant increase in 
ADHD by teacher ratings and OR 
1.37 (95% CI 1.07-1.75) non-
significant increase in high inattention 
symptom score by  maternal ratings. 
Pre-pregnancy obesity was 
associated with OR 2.05 (95% CI 
1.06-3.95) increase in ADHD 
symptoms by teacher ratings and OR 
1.89 (95% CI 1.13 – 3.15) increase in 
ADHD symptoms by maternal 
ratings. 
  
Table 3. Human studies linking maternal obesity with DNA methylation changes in the offspring 
Studies using global methylation techniques 
Study Population Design Country Tissue  Method Findings 
Michels, et al 
PLoS One. 
2011; 6: 
e25254. 
Epigenetic Birth 
Cohort 
 
319 newborns with 
316 placentas 
cohort USA Cord blood 
Placental 
tissue 
Global methylation using a LINE-1 
bisulfite pyrosequencing assay 
No associations between maternal 
prepregnancy BMI and global 
methylation in either tissue. 
Herbstman  
et al. 
PLoS One. 
2013; 8: 
e72824 
Northern Manhattan 
Mothers & Newborns 
Study of the Columbia 
Center for Children’s 
Environmental Health 
n = 279 newborns with 
n=165 at 3 year 
follow-up. 
cohort USA Cord blood 
 
Peripheral 
blood at 3 
years 
Global DNA methylation using the 
MethylampTM Global DNA Methylation 
Quantification Kit (Epigentek Group Inc, 
NY). 
Pre-pregnancy BMI was negatively 
predictive of both cord and three-
year DNA methylation. 
Morales, et al 
BMC Res 
Notes. 2014;  
7: 278.  
 
Avon Longitudinal 
Study of Parents and 
Children (ALSPAC) 
Cohort; n=88 term 
newborns. 
Replication study 
population including 
170 term newborns 
born 
cohort UK Cord blood GoldenGate Cancer Panel I Array 
(Illumina Inc, USA) 
 
 
 
Validation using A PyroMark MD 
Pyrosequencing System (Qiagen) in 
replication cohort 
No associations between maternal 
pre-pregnancy BMI and 
differentially methylated DNA at any 
CpG site 
 
No association of maternal pre-
pregnancy BMI using 
pyrosequencing in replication cohort 
Liu, et al, 
Environ Mol 
Mutagen 2014 
223–230. 
Boston Birth Cohort 
 
309 Black (African 
American and 
Haitian), term 
newborns 
cohort USA Cord blood Illumina HumanMethylation27BeadChip The methylation levels of 20 CpG 
sites were associated with maternal 
BMI. One CpG site (ZCCHC10) 
remained statistically significant 
after correction for multiple 
comparisons. 
Sharp et al, 
Int J Epidemiol 
2015; 44:1288-
304. 
ARIES (subset of 
ALSPAC) 
 
n-1018 
cohort UK Cord blood HumanMethylation 450 K Compared with neonatal offspring 
of normal weight mothers, 28 and 
1621 CpG sites were differentially 
methylated in offspring of obese 
and underweight mothers. A 
positive association, where higher 
methylation is associated with a 
body mass index (BMI) outside the 
normal range, was seen at 78.6% of 
the sites associated with obesity  
Guenard et al, 
J Obes. 2013; 
2013: 492170.  
 
50 siblings aged 
2 years 8 months to 
24 years 11 months, , 
born before and after 
maternal bariatric 
surgery (25 BMS and 
25 AMS offspring) 
case/ 
control 
 
Canada Peripheral 
blood 
Genome-wide methylation analysis 
using the Infinium 
HumanMethylation450 BeadChip 
5698 differentially methylated genes 
between BMS and AMS offspring. 
Main differences in inflammatory 
and immune pathways 
Studies using candidate gene approach 
Study Population Design Country Tissue  Method Findings 
Gemma et al,  
Obesity 
2009 ;17(5): 
1032-9. 
88 newborns: 57 
newborns with 
appropriate weight for 
gestational age 
(AGA), 17 SGA, and 
14 LGA 
cohort Argentina Umbilical 
cord 
PPARGC1A promoter 
After bisulphite treatment of umbilical 
cord genomic DNA, a real-time 
methylation-specific PCR was used to 
determine the promoter methylation 
status in selected CpGs 
positive correlation between 
maternal BMI and PPARGC1A 
promoter methylation in umbilical 
cord (Pearson correlation coefficient 
r = 0.41, P = 0.0007) 
Hoyo et al, 
Cancer Causes 
Control 
2012;23:635-
45 
438 participants in 
Newborn Epigenetics 
STudy (NEST) 
cohort USA Cord blood Bisulphite sequencinc Lower IGF2 DMR methylation was 
associated with elevated plasma 
IGF2 protein concentrations, an 
association that was stronger in 
infants born to obese women. 
Elevated IGF2 concentrations were 
associated with higher birth weight 
Soubry et al, 
BMC Mewd 
2013; 11:29 
79 newborns from the 
NEST cohort 
cohort USA Cord blood Bisulphite sequencing Increase in DNA methylation at the 
IGF2 and H19 DMRs among 
newborns from obese mothers 
Soubry et al, 
Int J Obes 
2015;39: 
650-7. 
92 newborns from the 
NEST cohort 
 
cohort USA Cord blood Bisulphite pyrosequencing Obesity in mothers was associated 
with an increase in methylation at 
the PLAGL1 DMR β-coefficient 
+2.58 (s.e.=1.00; P=0.01) and a 
decrease at the MEG DMR (β-
coefficient 3.42 (s.e.=1.69; P=0.04). 
Burris et al, 
Epigenetics 
2015; 10:913-
21. 
531 infants from 
Programming 
Research in Obesity, 
Growth Environment 
and Social Stress 
(PROGRESS) cohort 
 
cohort Mexico 
City 
Cord blood aryl-hydrocarbon receptor repressor 
(AHRR) DNA methylation by bisulphite 
sequencing 
AHRR DNA methylation was 
positively associated with maternal 
BMI (P = 0.0009) AHRR DNA 
methylation was 2.1% higher in 
offspring of obese vs. normal weight 
mothers representing a third of the 
standard deviation differences in 
methylation 
Table 4. Key points for future research 
 Molecular mechanisms:  Comprehensive experimental research is required into the 
epigenetic and other mechanisms linking maternal obesity to long term outcomes in the 
offspring. This will enable development of novel biomarkers and assist design of new 
intervention studies. 
• Lifestyle, nutritional and metabolic drivers: Detailed information is needed on the 
specific maternal lifestyle (e.g. physical activity, smoking, other environmental stressors), 
nutritional and metabolic exposures that underpin effects of maternal obesity on offspring 
outcomes. This needs to be combined with information on whether there are critical periods 
during development when such exposures have their effects and whether any outcomes 
are sex-specific. 
• Causality: Alongside mechanistic research, sophisticated observational studies are 
needed to obtain further insight into the (multiple) causalities of the observed associations. 
Such study designs include parent-offspring longitudinal cohorts, sib-pair analyses and the 
use of genetic variants and haplotypes as instrumental variables. 
• The need for new intervention studies: There is a paucity of intervention studies 
focused on remediation of maternal obesity before and during pregnancy, or on moderation 
of the effects of maternal obesity on the offspring. With a deeper understanding of the 
underlying mechanisms, new interventions need to be designed and tested, with long-term 
follow-up of the offspring. 
 
